Translational Development Acquisition Corp. Ordinary Shares (TDAC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.24 Million) by net assets ($173.52 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TDAC company net worth for the company's overall valuation and market capitalisation.
Translational Development Acquisition Corp. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Translational Development Acquisition Corp. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Translational Development Acquisition Corp. Ordinary Shares ranked by their cash flow conversion efficiency. Explore Translational Development Acquisition Co cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PTC India Financial Services Limited
NSE:PFS
|
0.379x |
|
Acme Electronics
TWO:8121
|
0.004x |
|
D2L Inc
TO:DTOL
|
-0.196x |
|
Savior Lifetec
TWO:4167
|
-0.026x |
|
S-Oil Corp Pref
KO:010955
|
0.103x |
|
Shanghai Jinqiao Export Processing Zone Development Co Ltd B
SHG:900911
|
-0.111x |
|
Bogazici Beton Sanayi ve Ticaret AS
IS:BOBET
|
0.087x |
|
Capitan Silver Corp.
V:CAPT
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
The table below shows the annual cash flow conversion efficiency of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2024. View Translational Development Acquisition Co (TDAC) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $168.75 Million | $-851.45K | -0.005x | -1355.59% |
| 2023-12-31 | $-507.66K | $-204.00 | 0.000x | -99.99% |
| 2022-12-31 | $-22.11K | $-97.16K | 4.395x | -- |
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.